Skip to content

Power Training in Older Type 2 Diabetics with Metabolic Syndrome: A Randomised, Double Blind, Sham Controlled, Longitudinal Trial

Power Training and Older Type 2 Diabetics with Metabolic Syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016599
Enrollment
Unknown
Registered
2018-06-11
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes and associated with complications

Interventions

Experimental Intervention:Power Training
Control group:Control group intervention

Sponsors

University of Longyan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusionary criteria were based on diagnosed type 2 diabetes, age, and physical activity level. Participants had to be over 60 years old and sedentary (no progressive resistance training; structured exercise = 1/week; less than 150min/week low or moderate-intensity walking or other aerobic exercises). Participants could be treated with diet alone, oral medications or insulin or combination at the time of enrolment. Metabolic syndrome was defined according to the International Diabetes Federation as: Central obesity (defined as waist circumference = 90 cm for Chinese men and = 80 cm for Chinese women, plus any 2 of the following 4 factors: * Raised TG level: = 1.7 mmol/L, or specific treatment for this lipid abnormality; * Reduced HDL cholesterol: < 1.03 mmol/L) in men or < 1.29 mmol/L in women, or specific treatment for this lipid abnormality; * Raised resting blood pressure: systolic blood pressure (BP) = 130 mmHg or diastolic BP =85 mmHg, or treatment of previously diagnosed hypertension; * Raised fasting plasma glucose (FPG) = 5.6 mmol/L, or previously diagnosed T2D.

Exclusion criteria

Exclusion criteria: Exclusionary criteria included significant cognitive impairment, non-ambulatory status or lower extremity amputation other than toes, current alcohol or substance abuse, inability to comply with study requirements over the course of one year due to travel plans or other commitments, and specific contraindications to resistance training exercise, such as unstable cardiovascular disease, unrepaired aortic aneurysm, symptomatic hernias, proliferative diabetic retinopathy, or rapidly progressive or terminal illness. Temporary exclusions (any change in dosage or type of diabetic medications within the past 3 months, retinal laser surgery within 6 weeks, uncontrolled hypertension) were resolved prior to study enrolment and screening procedure.

Design outcomes

Primary

MeasureTime frame
Insulin Sensitivity, Glucose Homeostasis;

Secondary

MeasureTime frame
Cardiovascular Health, Lipid Metabolism, Muscle Metabolism, Adipokines, Inflammatory Markers, Body Composition, Exercise Capacity and Functional Status, Neuropsychological Profile, Health-Related Quality of Life, Nutritional Intake, Energy Expenditurey and Actigraph accelerometers, Brain structure, biochemistry, and function.;

Countries

China

Contacts

Public ContactREN RU ZHAO

The University of Longyan

rzha6475@uni.sydney.edu.au+86 0597-3305523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026